These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

340 related items for PubMed ID: 16026247

  • 1. Plasmid DNA vaccines against cancer: cytotoxic T-lymphocyte induction against tumor antigens.
    Pavlenko M, Leder C, Pisa P.
    Expert Rev Vaccines; 2005 Jun; 4(3):315-27. PubMed ID: 16026247
    [Abstract] [Full Text] [Related]

  • 2. Induction of multiepitopic and long-lasting immune responses against tumour antigens by immunization with peptides, DNA and recombinant adenoviruses expressing minigenes.
    Durántez M, López-Vázquez AB, de Cerio AL, Huarte E, Casares N, Prieto J, Borrás-Cuesta F, Lasarte JJ, Sarobe P.
    Scand J Immunol; 2009 Feb; 69(2):80-9. PubMed ID: 19144076
    [Abstract] [Full Text] [Related]

  • 3. Engineering enhancement of the immune response to HBV DNA vaccine in mice by the use of LIGHT gene adjuvant.
    Zhang Y, Jiang W, Fan Y, Wen J, Hao W, Qian M.
    J Virol Methods; 2008 Nov; 153(2):142-8. PubMed ID: 18722475
    [Abstract] [Full Text] [Related]

  • 4. Vaccination with liposome--DNA complexes elicits enhanced antitumor immunity.
    U'Ren L, Kedl R, Dow S.
    Cancer Gene Ther; 2006 Nov; 13(11):1033-44. PubMed ID: 16841080
    [Abstract] [Full Text] [Related]

  • 5. DNA fusion gene vaccines against cancer: from the laboratory to the clinic.
    Stevenson FK, Rice J, Ottensmeier CH, Thirdborough SM, Zhu D.
    Immunol Rev; 2004 Jun; 199():156-80. PubMed ID: 15233733
    [Abstract] [Full Text] [Related]

  • 6. DNA vaccination against tumors.
    Prud'homme GJ.
    J Gene Med; 2005 Jan; 7(1):3-17. PubMed ID: 15538731
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. A MUC1/IL-18 DNA vaccine induces anti-tumor immunity and increased survival in MUC1 transgenic mice.
    Snyder LA, Goletz TJ, Gunn GR, Shi FF, Harris MC, Cochlin K, McCauley C, McCarthy SG, Branigan PJ, Knight DM.
    Vaccine; 2006 Apr 12; 24(16):3340-52. PubMed ID: 16472547
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. [Novel vaccines against M. tuberculosis].
    Okada M.
    Kekkaku; 2006 Dec 12; 81(12):745-51. PubMed ID: 17240920
    [Abstract] [Full Text] [Related]

  • 11. DNA-based vaccination against tumors expressing the P1A antigen.
    Rosato A, Milan G, Collavo D, Zanovello P.
    Methods; 1999 Sep 12; 19(1):187-90. PubMed ID: 10525455
    [Abstract] [Full Text] [Related]

  • 12. Induction of immune response and anti-tumor activities in mice with a DNA vaccine encoding human mucin 1 variable-number tandem repeats.
    Zhang S, Zhang H, Shi H, Yu X, Kong W, Li W.
    Hum Immunol; 2008 Sep 12; 69(4-5):250-8. PubMed ID: 18486759
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Dendritic cell-tumor cell hybrids enhance the induction of cytotoxic T lymphocytes against murine colon cancer: a comparative analysis of antigen loading methods for the vaccination of immunotherapeutic dendritic cells.
    Yasuda T, Kamigaki T, Nakamura T, Imanishi T, Hayashi S, Kawasaki K, Takase S, Ajiki T, Kuroda Y.
    Oncol Rep; 2006 Dec 12; 16(6):1317-24. PubMed ID: 17089056
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Vaccination with an adenoviral vector encoding the tumor antigen directly linked to invariant chain induces potent CD4(+) T-cell-independent CD8(+) T-cell-mediated tumor control.
    Sorensen MR, Holst PJ, Pircher H, Christensen JP, Thomsen AR.
    Eur J Immunol; 2009 Oct 12; 39(10):2725-36. PubMed ID: 19637230
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Individual analysis of mice vaccinated against a weakly immunogenic self tumor-specific antigen reveals a correlation between CD8 T cell response and antitumor efficacy.
    Rosato A, Zoso A, Milan G, Macino B, Dalla Santa S, Tosello V, Di Carlo E, Musiani P, Whalen RG, Zanovello P.
    J Immunol; 2003 Nov 15; 171(10):5172-9. PubMed ID: 14607917
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 17.